Skip to main content
Premium Trial:

Request an Annual Quote

IP Roundup: Life Technologies, Theranos, Bioinfra

Premium

Life Technologies of Carlsbad, Calif., has received US Patent No. 8,435,395, "Methods and apparatus for measuring analytes using large scale FET arrays." Methods are claimed for producing large-scale, filed-effect-transistor arrays using conventional complementary metal–oxide–semiconductor processing techniques. According to the inventors, such arrays may be employed to detect a presence or concentration changes of various analyte types in a variety of chemical and biological processes.


Bioinfra of Seoul, South Korea, has received US Patent No. 8,435,748, "Method for monitoring, diagnosing, and screening cancer through measuring the concentration of des-R prothrombin activation peptide fragment F2 (des-R F2) in a serum." The patent claims a method of diagnosing cancer in an individual by measuring the expression of des-R-prothrombin activation peptide fragment F2 in blood, serum and plasma samples. According to the patent, the expression may be measured using a kit or biochip containing antibodies specifically binding to des-R prothrombin activation peptide fragment F2. By comparing the measured expression level of des-R-prothrombin activation peptide fragment F2 in the sample of the test subject with a normal subject, the inventors believe that they can determine if the subject has a cancer.


Theranos of Palo Alto, Calif., has received US Patent No. 8,435,738, "Systems and methods for multi-analysis." The patent describes a system that consists of modules mounted on a support structure. According to the patent, these modules include a sample preparation station, an assay station, an a detection station. The system is configured to perform sample preparation procedures and multiple types of assays, such as immunoassays, nucleic acid assays, receptor-based assays, and others. According to the patent, the multiple types of assays are performed with the aid of isolated units contained within the system.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.